(A) In the dStr, PTX (100 μM) continued to produce a greater enhancement of 10 p- versus 1 p-evoked [DA]o in the presence of a mGluR1 antagonist (JNJ-16259685, 10 μM) and significantly increased the ratio of phasic (10 p) to tonic (1 p) DA signaling (n = 6 mice, paired t test).
(B) In the NAc core, greater enhancement of 10 p- versus 1 p-evoked [DA]o with PTX persisted in a cocktail of antagonists for AMPARs (DNQX, 10 μM) and NMDARs (D-AP5, 50 μM), as did the increased ratio of phasic-to-tonic DA release (n = 6 mice, paired t test).
(C) In the dStr, PTX continued to produce a greater enhancement of 10 p- versus 1 p-evoked [DA]o in the presence of a nAChR antagonist (DHβE, 1 μM) and significantly increased the ratio of phasic (10 p) to tonic (1 p) DA signaling (n = 6 mice, paired t test).
**p < 0.01, ***p < 0.001 versus respective 1 p stimulation or control (paired t tests) in males (blue circles) plus females (orange circles). Data are mean ± SEM.